GlassScriptPhysician profile
William J Johncox
NPI 1023124278
$5,612.02
in general payments reported to CMS, 2019-2025
13 companies · $151 in 2025
The $151 reported for 2025 was less than what a typical Medical provider received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $369 · 2022: $3,433 · 2023: $1,390 · 2024: $270 · 2025: $151.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,227 · Travel and Lodging: $584.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,226.67 |
| Travel and Lodging | $583.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $4,353.20 | 2021-2024 | Synchromedii, Intellis Adaptivestim |
| Abbott Laboratories | $314.22 | 2021-2025 | Proclaim |
| Boston Scientific Corporation | $266.24 | 2021-2025 | General - Pain Management |
| Relievant Medsystems, INC. | $207.85 | 2021-2023 | Intracept |
| Nevro Corp. | $191.54 | 2021-2023 | Senza |
| Vertos Medical, INC. | $81.10 | 2021-2023 | Mild Device Kit |
| Kowa Pharmaceuticals America, INC. | $46.13 | 2022 | |
| Vertex Pharmaceuticals Incorporated | $38.62 | 2025 | |
| Spr Therapeutics, INC | $34.63 | 2022-2023 | Sprint Pns System |
| Forte Bio-Pharma LLC | $21.97 | 2021 | |
| Scilex Pharmaceuticals INC. | $21.51 | 2022 | |
| Virtus Pharmaceuticals LLC | $18.01 | 2025 | Levorphanol Tartrate |
| Curonix LLC | $17.00 | 2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Johncox listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.